Linklaters advised McKesson on the sale of its Austrian business to Quadrifolia Management by way of a management buy-out
Linklaters advised McKesson Corporation, a global leader in health care supply chain management solutions and retail pharmacy, on the sale of its Austrian business to Quadrifolia Management GmbH by way of a management buy-out (MBO).
The MBO comprised the sale of McKesson's Austrian business, mainly consisting of Herba Chemosan Apotheker-AG and Sanova Pharma GesmbH.
Quadrifolia Management GmbH, the purchaser of the McKesson Austria business, has been established for purposes of the MBO by the Management Board members of Herba Chemosan – Andreas Windischbauer, Andreas Janka and Maximilian von Künsberg Sarre – and the private equity company Invest AG.
The transaction was successfully completed on 31 January 2022 and marks another milestone for McKesson to streamline their portfolio and to implement their strategy to exit the European market.
Linklaters, together with Herbst Kinsky Austria, advised McKesson on all legal aspects of the transaction.
The Linklaters team was led by Jochen Laufersweiler (Partner) and Andrea Pecina (Managing Associate), both Corporate/M&A, Frankfurt.